Personalizing Perioperative Analgesia in Children
Predicting Perioperative Opioid Adverse Effects and Personalizing Analgesia in Children
2 other identifiers
observational
1,200
1 country
1
Brief Summary
In the United States alone, each year approximately 5 million children undergo painful surgery, many of them experience serious side-effects with opioids and inadequate pain relief. Safe and effective analgesia is an important unmet critical medical need in children and its continued existence is an important perioperative safety and economic problem. Inadequate pain relief and serious side effects from perioperative opioids occur frequently in up to 50% of children. Morphine, the most commonly used perioperative opioid, has a narrow therapeutic index and large inter-patient variations in analgesic response and serious side effects. Frequent inter-individual variations in responses to morphine have significant clinical and economic impact with inadequate pain relief at one end of the spectrum of responses and serious adverse effects such as respiratory depression at the other end. Much of the inter-individual variability in response to a dose of morphine following surgical procedures can be explained by single nucleotide polymorphisms (SNPs) in a subset of the genes that encode proteins involved in pain mechanisms and opioid pathway.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 8, 2010
CompletedFirst Posted
Study publicly available on registry
June 9, 2010
CompletedStudy Start
First participant enrolled
February 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2026
ExpectedFebruary 2, 2026
April 1, 2025
6 months
June 8, 2010
January 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Look at polymorphisms in genes that regulate pain perception, opioid transport and opioid receptor signaling to see if there is a higher susceptibility to pain and morphine requirement.
Look at polymorphisms in genes that regulate pain perception, opioid transport and opioid receptor signaling to see if there is a relationship to more pain and need for a higher morphine requirement.
After tonsillectomy surgery (duration of post anesthesia care unit stay)
Secondary Outcomes (1)
Evaluate relationship of pupil reaction and response to 5% carbon dioxide to adverse effects of morphine
After tonsillectomy surgery (duration of post anesthesia care unit stay)
Other Outcomes (2)
Evaluate contribution of polymorphisms in genes to variability in codeine response in children with CYP2D6 genotypes predictive of extensive metabolizer or ultra-extensive metabolizer phenotypes
During tonsilectomies
Evaluate whether machine learning techniques can be used to predict pain response, opioid responses and morphine usage requirements in patients
After tonsilectomy surgery data collection
Eligibility Criteria
Children, 3-15 years of age, undergoing tonsillectomy or adenotonsillectomy at the Riley Hospital for Children, who have consented to participate in an observational clinical study as approved by the IU IRB, protocol # 1707325115.
You may qualify if:
- boys and girls,
- years of age,
- all races,
- American Society of Anesthesiologists (ASA) physical status 1,2, and 3,
- children with history of significant snoring suggestive of obstructive sleep apnea (OSA),
- Scheduled for tonsillectomy (T) or tonsillectomy and adenoidectomy (T and A).
You may not qualify if:
- allergic to study medications
- developmental delay,
- liver and renal diseases,
- preoperative pain requiring analgesics,
- children who have problems with pupil or pupillary reaction due to disease
- preoperative medications influencing pupillary size
- non-English speaking participants and families
- Body Mass Index ≥30
- Participants undergoing additional procedures during surgery
- Children with certain cardiac conditions
- Children with severe lung disease
- Children with a history of seizures currently treated on medication
- Children with psychiatric/psychological conditions for which patient currently takes medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UPMC Children's Hospital
Pittsburgh, Pennsylvania, 15224, United States
Related Publications (9)
Packiasabapathy S, Zhang X, Ding L, Aruldhas BW, Pawale D, Sadhasivam S. Quantitative Pupillometry as a Predictor of Pediatric Postoperative Opioid-Induced Respiratory Depression. Anesth Analg. 2021 Oct 1;133(4):991-999. doi: 10.1213/ANE.0000000000005579.
PMID: 34029273DERIVEDHahn D, Fukuda T, Euteneuer JC, Mizuno T, Vinks AA, Sadhasivam S, Emoto C. Influence of MRP3 Genetics and Hepatic Expression Ontogeny for Morphine Disposition in Neonatal and Pediatric Patients. J Clin Pharmacol. 2020 Aug;60(8):992-998. doi: 10.1002/jcph.1592. Epub 2020 Feb 24.
PMID: 32090339DERIVEDChidambaran V, Venkatasubramanian R, Zhang X, Martin LJ, Niu J, Mizuno T, Fukuda T, Meller J, Vinks AA, Sadhasivam S. ABCC3 genetic variants are associated with postoperative morphine-induced respiratory depression and morphine pharmacokinetics in children. Pharmacogenomics J. 2017 Mar;17(2):162-169. doi: 10.1038/tpj.2015.98. Epub 2016 Jan 26.
PMID: 26810133DERIVEDSadhasivam S, Zhang X, Chidambaran V, Mavi J, Pilipenko V, Mersha TB, Meller J, Kaufman KM, Martin LJ, McAuliffe J. Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects. Pharmacogenomics J. 2015 Oct;15(5):436-42. doi: 10.1038/tpj.2014.79. Epub 2015 Jan 6.
PMID: 25558980DERIVEDSadhasivam S, Chidambaran V, Olbrecht VA, Costandi A, Clay S, Prows CA, Zhang X, Martin LJ. Opioid-related adverse effects in children undergoing surgery: unequal burden on younger girls with higher doses of opioids. Pain Med. 2015 May;16(5):985-97. doi: 10.1111/pme.12660. Epub 2014 Dec 17.
PMID: 25521773DERIVEDSadhasivam S, Chidambaran V, Olbrecht VA, Esslinger HR, Zhang K, Zhang X, Martin LJ. Genetics of pain perception, COMT and postoperative pain management in children. Pharmacogenomics. 2014 Feb;15(3):277-84. doi: 10.2217/pgs.13.248.
PMID: 24533707DERIVEDProws CA, Zhang X, Huth MM, Zhang K, Saldana SN, Daraiseh NM, Esslinger HR, Freeman E, Greinwald JH, Martin LJ, Sadhasivam S. Codeine-related adverse drug reactions in children following tonsillectomy: a prospective study. Laryngoscope. 2014 May;124(5):1242-50. doi: 10.1002/lary.24455. Epub 2013 Nov 13.
PMID: 24122716DERIVEDSadhasivam S, Krekels EH, Chidambaran V, Esslinger HR, Ngamprasertwong P, Zhang K, Fukuda T, Vinks AA. Morphine clearance in children: does race or genetics matter? J Opioid Manag. 2012 Jul-Aug;8(4):217-26. doi: 10.5055/jom.2012.0119.
PMID: 22941849DERIVEDSadhasivam S, Chidambaran V, Ngamprasertwong P, Esslinger HR, Prows C, Zhang X, Martin LJ, McAuliffe J. Race and unequal burden of perioperative pain and opioid related adverse effects in children. Pediatrics. 2012 May;129(5):832-8. doi: 10.1542/peds.2011-2607. Epub 2012 Apr 23.
PMID: 22529273DERIVED
Biospecimen
DNA from blood is obtained and analyzed for genetic varaiations
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Senthilkumar Sadhasivam, MD, MPH
University of Pittsburgh, UPMC
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 8, 2010
First Posted
June 9, 2010
Study Start
February 7, 2022
Primary Completion
August 16, 2022
Study Completion (Estimated)
December 25, 2026
Last Updated
February 2, 2026
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share